What adjustments should be made to the insulin regimen for a patient whose fasting and post‑prandial glucose remain approximately 300 mg/dL while taking sitagliptin 50 mg daily, insulin lispro 9 units subcutaneously three times daily, and insulin glargine 44 units subcutaneously once daily?

Immediate Insulin Intensification Required

This patient requires urgent upward titration of both basal and prandial insulin doses—the current regimen is grossly inadequate for glucose levels consistently around 300 mg/dL. 1

Immediate Actions

1. Increase Basal Insulin (Glargine)

• Increase glargine by 4 units immediately (current dose: 44 units → 48 units) 1
• Continue increasing by 2 units every 3 days until fasting plasma glucose reaches 90-130 mg/dL 1, 2
• The 2025 ADA Standards explicitly recommend this evidence-based titration algorithm for patients not at fasting glucose goal 1

2. Increase Prandial Insulin (Lispro)

• Increase each lispro dose by 1-2 units (current 9 units → 10-11 units three times daily) 1
• Alternatively, increase by 10-15% of current dose 1
• Titrate the dose before the meal with the highest postprandial glucose excursion most aggressively
• Continue adjusting every 2-3 days based on pre-meal and 2-hour postprandial readings 3

3. Monitor Intensively

• Check fasting glucose daily to guide basal titration 1
• Check pre-meal and 2-hour postprandial glucose to guide prandial adjustments 1
• During insulin regimen changes, increase frequency of blood glucose monitoring per FDA labeling 2

Key Clinical Considerations

Hypoglycemia Management Protocol:

• If hypoglycemia occurs without clear cause, reduce the corresponding insulin dose by 10-20% 1
• Prescribe glucagon for emergent hypoglycemia 1

Sitagliptin Role:

• Continue sitagliptin 50 mg daily—it provides complementary glucose-lowering without significant hypoglycemia risk
• The DPP-4 inhibitor can remain as adjunctive therapy during insulin intensification

Expected Insulin Requirements:

• This patient's total daily insulin dose is currently only 71 units (44 basal + 27 prandial)
• For type 2 diabetes with severe hyperglycemia, total daily requirements often reach 0.5-1.0 units/kg 4
• Most patients achieving HbA1c ≤7% require 40-70 units/day or more 5—this patient likely needs substantially more insulin

Titration Algorithm Moving Forward

Every 3 days, assess:

1. Fasting glucose <90 mg/dL: Decrease basal by 2 units
2. Fasting glucose 90-130 mg/dL: No change to basal
3. Fasting glucose 131-180 mg/dL: Increase basal by 2 units
4. Fasting glucose >180 mg/dL: Increase basal by 4 units 1

For prandial insulin:

• Adjust each meal's dose independently based on the 2-hour postprandial glucose after that specific meal
• Target postprandial glucose <180 mg/dL 1

Critical Pitfalls to Avoid

Do NOT delay intensification. Glucose levels of 300 mg/dL represent severe hyperglycemia requiring aggressive intervention 1, 3. The 2025 ADA guidelines explicitly state that when blood glucose ≥300 mg/dL, insulin should be considered as first-line therapy and titrated aggressively 1.

Avoid therapeutic inertia. The current regimen has clearly failed—reassess and modify regularly every 3-6 months, but with severe hyperglycemia like this, adjustments should occur every 2-3 days until control is achieved 1.

Watch for overbasalization. If fasting glucose reaches goal but postprandial glucose remains elevated (>180 mg/dL), this signals the need to increase prandial insulin rather than continuing to push basal insulin higher 1.